These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39211930)
21. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus. Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724 [TBL] [Abstract][Full Text] [Related]
22. Novel small-molecule compound YH7 inhibits the biofilm formation of Xiao Y; Wan C; Wu X; Xu Y; Chen Y; Rao L; Wang B; Shen L; Han W; Zhao H; Shi J; Zhang J; Song Z; Yu F mSphere; 2024 Jan; 9(1):e0056423. PubMed ID: 38170984 [TBL] [Abstract][Full Text] [Related]
23. In silico and in vitro studies of GENT-EDTA encapsulated niosomes: A novel approach to enhance the antibacterial activity and biofilm inhibition in drug-resistant Klebsiella pneumoniae. Akbarzadeh I; Rezaei N; Bazzazan S; Mezajin MN; Mansouri A; Karbalaeiheidar H; Ashkezari S; Moghaddam ZS; Lalami ZA; Mostafavi E Biomater Adv; 2023 Jun; 149():213384. PubMed ID: 37060635 [TBL] [Abstract][Full Text] [Related]
24. Novel Niosome-Encapsulated 2,5-Diketopiperazine (BHPPD): Synthesis, Formulation, and Anti-breast Cancer Activity. Ghourchian H; Pecho RDC; Karimi-Dehkordi M; Mazandarani A; Ghajari G; Piri-Gharaghie T Appl Biochem Biotechnol; 2024 Jun; 196(6):3126-3147. PubMed ID: 37624507 [TBL] [Abstract][Full Text] [Related]
34. Ultra-deformable free fatty acid based nano-carriers for topical delivery of Luteolin: A potential paradigm for management of Methicillin-Resistant Staphylococcus aureus skin infections. Zakaria MY; Eraqi WA; Mohamed SA Int J Pharm; 2023 Aug; 643():123259. PubMed ID: 37479100 [TBL] [Abstract][Full Text] [Related]
35. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria. Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153 [TBL] [Abstract][Full Text] [Related]
36. Preparation, Physicochemical Characterization, Antimicrobial Effects, Biocompatibility and Cytotoxicity of Co-Loaded Meropenem and Vancomycin in Mesoporous Silica Nanoparticles. Yekani M; Azargun R; Sharifi S; Sadri Nahand J; Hasani A; Ghanbari H; Sadat Seyyedi Z; Memar MY; Maleki Dizaj S Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002075 [TBL] [Abstract][Full Text] [Related]
37. Antibacterial Activity and Mechanism of Canagliflozin against Methicillin-Resistant Gu S; Fan B; Wan F; Gao T; Qi Y; Zhou J; Zhang Y; Gu D; Xie W Molecules; 2023 Jul; 28(15):. PubMed ID: 37570637 [TBL] [Abstract][Full Text] [Related]
38. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus. Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp. Yoneda A; Thänert R; Burnham CD; Dantas G Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598 [TBL] [Abstract][Full Text] [Related]
40. Antibacterial and anti-biofilm activity of radezolid against Wang C; Xiong Y; Bao C; Wei Y; Wen Z; Cao X; Yu Z; Deng X; Li G; Deng Q Front Microbiol; 2023; 14():1131178. PubMed ID: 37180277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]